Apyx Medical Corp (APYX)

AI-Powered SEC Filing Analysis

Current Report Filed: 2026-03-10

Key Insights

Apyx Medical Corporation reported its financial results for the fourth quarter and full year ended December 31, 2025, which appears to be a material update for investors.
The company's press release indicates that they will be providing more details on their operating and financial performance during the reported period, which could help investors assess the company's ongoing business trends.
Investors should review the full earnings report and any forward-looking guidance provided by the company to better understand the drivers of its recent performance and future outlook.

Annual Report Filed: 2026-03-10

Key Insights

Apyx Medical Corp has a robust information security program that includes regular risk assessments, audits, and oversight by the Board of Directors.
The company outsources the majority of its IT services and security to a well-respected industry provider, which helps strengthen its cybersecurity posture.
Apyx's CISO and CFO provide quarterly updates and annual risk assessment/audit results to the Board, demonstrating the company's proactive approach to managing cybersecurity risks.

Insider Trading Filed: 2026-01-29

Key Insights

Shawn Roman, the Chief Operating Officer, exercised 12,000 stock options granted in 2016 at a price of $1.80 per share, indicating his ongoing commitment to the company.
The transaction was executed through The Roman Family Revocable Trust, over which Shawn Roman has beneficial ownership, suggesting the shares are held for long-term investment rather than short-term trading.
The exercise of stock options could provide Shawn Roman with additional equity in the company, potentially aligning his interests with those of other shareholders.

Current Report Filed: 2026-01-12

Key Insights

Apyx Medical Corporation reported preliminary revenue results for Q4 and full-year 2025, indicating potential growth that could be of interest to investors.
The company did not provide detailed financial information or forward guidance in this 8-K filing, limiting the scope of analysis.
Investors may want to monitor the company's upcoming full earnings report for more comprehensive financial details and management's commentary on business performance and outlook.

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.